Koers Pure Harvest Corporate Group, Inc. Other OTC
Aandelen
PHCG
US74625M1018
Farmaceutische producten
Omzet 2019 | 0,04 0,04 | Omzet 2020 | 0,74 0,68 | Marktkapitalisatie | 31,42 mln. 28,93 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | -1 mln. -921K | Nettowinst (verlies) 2020 | -6 mln. -5,53 mln. | EV/omzet 2019 | 430.896.057 x |
Nettoliquiditeiten 2019 | 457K 421K | Nettoschuld 2020 | 2,87 mln. 2,64 mln. | EV/omzet 2020 | 46.605.076 x |
K/w-verhouding 2019 |
-15,5
x | K/w-verhouding 2020 |
-3,88
x | Werknemers | - |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 62,22% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Matthew Gregarek
CEO | Chief Executive Officer | 44 | 02-07-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Matthew Gregarek
CEO | Chief Executive Officer | 44 | 02-07-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,06% | 6,19 mld. | |
-15,95% | 4,48 mld. | |
+6,36% | 3,29 mld. | |
-11,34% | 3,12 mld. | |
-3,12% | 2,5 mld. | |
+45,41% | 1,94 mld. | |
-7,74% | 1,68 mld. | |
-0,67% | 1,64 mld. | |
-11,32% | 1,56 mld. |